Go Pro
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$1.75 +0.05 (+2.94%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$1.74 0.00 (-0.29%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Advanced

Key Stats

Today's Range
$1.70
▼
$1.76
50-Day Range
$1.53
▼
$2.39
52-Week Range
$0.96
▼
$3.62
Volume
243,400 shs
Average Volume
444,980 shs
Market Capitalization
$131.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.45
Consensus Rating
Hold

Company Overview

Health Catalyst, Inc. is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery. Health Catalyst also provides implementation, advisory and managed services to help customers develop data-driven strategies and put analytics into practice.

Founded in 2008 and headquartered in South Jordan, Utah, Health Catalyst primarily serves healthcare organizations in the United States. The company went public on the Nasdaq under the symbol HCAT in 2019. Dan Burton has served as Health Catalyst’s chief executive officer since 2017.

AI Generated. May Contain Errors.

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 77% of companies evaluated by MarketBeat, and ranked 127th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on no strong buy ratings, 3 buy ratings, 7 hold ratings, and 1 sell rating.

  • Upside Potential

    Health Catalyst has a consensus price target of $2.45, representing about 40.0% upside from its current price of $1.75.

  • Amount of Analyst Coverage

    Health Catalyst has only been the subject of 4 research reports in the past 90 days.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to decrease in the coming year, from ($0.18) to ($0.19) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Health Catalyst's valuation and earnings.
  • Percentage of Shares Shorted

    3.34% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 3.93, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Health Catalyst has recently increased by 3.96%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • News Sentiment

    Health Catalyst has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Health Catalyst this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $105,610.00 in company stock, which represents 0.0802% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have bought more of their company's stock than they have sold. Specifically, they have bought $105,610.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    19.40% of the stock of Health Catalyst is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCAT Stock News Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Health Catalyst (NASDAQ:HCAT) CEO Acquires 59,000 Shares
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $2.39 at the beginning of the year. Since then, HCAT shares have decreased by 26.8% and is now trading at $1.75.

Health Catalyst, Inc. (NASDAQ:HCAT) announced its quarterly earnings data on Thursday, August, 6th. The company reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.01. The firm had revenue of $70.49 million for the quarter, compared to analyst estimates of $69.09 million. Health Catalyst had a negative trailing twelve-month return on equity of 1.83% and a negative net margin of 90.61%.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $172 million in an initial public offering on Wednesday, July 24th 2019. The company issued 7,000,000 shares at a price of $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/06/2026
Today
10/04/2026
Next Earnings (Estimated)
11/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,200
Year Founded
2008

Price Target and Rating

High Price Target
$4.00
Low Price Target
$1.50
Potential Upside/Downside
+40.0%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.97 million
Net Margins
-90.61%
Pretax Margin
-90.22%
Return on Equity
-1.83%
Return on Assets
-0.80%

Debt

Debt-to-Equity Ratio
1.51
Current Ratio
2.70
Quick Ratio
2.70

Sales & Book Value

Annual Sales
$311.14 million
Price / Sales
0.42
Cash Flow
$2.13 per share
Price / Cash Flow
0.82
Book Value
$3.47 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
75,260,000
Free Float
60,656,000
Market Cap
$131.71 million
Optionable
Optionable
Beta
1.54

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners